The study, published Feb. 4 in Vaccines, looked at data from 296 UConn Health workers, including 46 who already had COVID-19. Participants were vaccinated with either the Pfizer or the Moderna mRNA vaccine. Researchers studied their blood for neutralizing antibodies at two months, five months and nine months post-vaccination.
Participants who had symptoms following the vaccination such as fever, aches or a sore arm had a stronger and longer lasting neutralizing antibody response. The response outperformed both those who had COVID-19 before the vaccine and those who had not, according to the study.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
